Wealthspire Advisors (Maryland)’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
Sell
-200
Closed -$2K 2642
2018
Q4
$2K Hold
200
﹤0.01% 2173
2018
Q3
$3K Hold
200
﹤0.01% 2096
2018
Q2
$2K Hold
200
﹤0.01% 2229
2018
Q1
$2K Hold
200
﹤0.01% 2247
2017
Q4
$2K Hold
200
﹤0.01% 2204
2017
Q3
$1K Buy
+200
New +$1K ﹤0.01% 2178